Search results for: 'group purchase organization'

This research report profiles, analyzes, and benchmarks the key buying groups and distributors in the European independent aftermarket distribution ecosystem. The regional scope of the research is EU4 (Germany, France, Italy, Spain) + UK. The base year for the analysis is 2021. Revenue analysis is carried out for 2019 and 2021 as a measure to ident...

Basal media, fetal bovine media, and balanced salt solutions are prevalent cell culture media. However, serum free media and growth, as well as attachment factors, are expected to see increased use in 2013 because current non-users are planning to include them in their workflow. Overall, Asia-Pacific is still a growing market in terms of the numbe...

19 Nov 2020  |  North America  |  Market Research

Strategic Analysis of the Fiat Chrysler Automobiles and PSA Group Merger

With $170 Billion in Revenue, 8.5 Million in Vehicle Sales, $6.5 Billion in R&D Potential and $4 Billion in Synergies, the FCA-PSA Merger is Poised to Give Strong Competition to Global Automakers

Infographics

×

The proposed merger between the Fiat Chrysler Automobiles (FCA) and the PSA Group is one of the most significant mergers among automotive original equipment manufacturers (OEMs). The merged company will be called Stellantis and will become the fourth-largest automotive OEM in terms of sales volume. This mega consolidation is driven by the need for ...

The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiolo...

10 May 2023  |  Global  |  Market Research

Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential

Infographics

×

This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...

This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are...

27 Nov 2019  |  North America  |  Market Research

Global Contract Research Organization (CRO) Market, Forecast to 2024

Increased Technology Adoption in the Form of eClinical Solutions and Innovative Trial Designs is Expected to Transform the CRO Landscape

Infographics

×

Key Issues Addressed

Increased technology adoption in the form of eClinical solutions and innovative trial designs is expected to transform the CRO landscape. Owing to a constantly changing pharmaceutical landscape, the industry is expected to witness a moderate 4% to 5% growth in the next 5 to 7 years, to surpass $1.5 trillion by 2025. In coordination with the indust...

Vaccines represent a class of biologics that are administered to prevent infectious diseases to reduce mortality and morbidity. It is estimated that the introduction of vaccines has reduced the incidence of various diseases by greater than 90%. This study examines the global vaccines market, including marketed products and products under clinical d...